TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Marksans Pharma Limited ( (IN:MARKSANS) ) has issued an announcement.
Marksans Pharma Limited has announced its unaudited financial results for the quarter and half year ending September 30, 2025, which were approved by the Board of Directors. The results, reviewed by the statutory auditors with an unmodified opinion, reflect the company’s ongoing financial performance and are available on their website, indicating transparency and compliance with regulatory standards.
More about Marksans Pharma Limited
Marksans Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceutical formulations. The company serves various markets globally, providing a range of products aimed at improving health and wellness.
Average Trading Volume: 94,593
Technical Sentiment Signal: Hold
Current Market Cap: 89.09B INR
For detailed information about MARKSANS stock, go to TipRanks’ Stock Analysis page.